[TENAGA] YoY Quarter Result on 31-Dec-2018 [#4]

Announcement Date
28-Feb-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
31-Dec-2018 [#4]
Profit Trend
QoQ- -126.81%
YoY- -122.24%
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/08/17 31/08/16 CAGR
Revenue 15,735,100 10,324,300 12,177,100 12,546,800 4,220,100 12,463,800 11,236,700 6.51%
PBT 822,000 891,600 774,800 202,700 759,100 2,152,400 1,872,300 -14.29%
Tax 170,500 310,200 -190,700 -354,300 -171,900 -417,900 -135,900 -
NP 992,500 1,201,800 584,100 -151,600 587,200 1,734,500 1,736,400 -9.94%
-
NP to SH 877,800 1,211,900 653,300 -134,300 603,900 1,719,200 1,762,200 -12.24%
-
Tax Rate -20.74% -34.79% 24.61% 174.79% 22.65% 19.42% 7.26% -
Total Cost 14,742,600 9,122,500 11,593,000 12,698,400 3,632,900 10,729,300 9,500,300 8.58%
-
Net Worth 56,523,361 55,758,924 57,981,810 57,716,936 57,155,513 57,110,490 52,397,511 1.43%
Dividend
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/08/17 31/08/16 CAGR
Div 1,029,152 3,304,300 3,980,822 1,305,248 1,212,063 2,489,953 1,241,780 -3.45%
Div Payout % 117.24% 272.65% 609.34% 0.00% 200.71% 144.83% 70.47% -
Equity
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/08/17 31/08/16 CAGR
Net Worth 56,523,361 55,758,924 57,981,810 57,716,936 57,155,513 57,110,490 52,397,511 1.43%
NOSH 5,726,091 5,704,653 5,686,888 5,686,888 5,665,986 5,658,986 5,644,458 0.26%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/08/17 31/08/16 CAGR
NP Margin 6.31% 11.64% 4.80% -1.21% 13.91% 13.92% 15.45% -
ROE 1.55% 2.17% 1.13% -0.23% 1.06% 3.01% 3.36% -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/08/17 31/08/16 CAGR
RPS 275.21 181.22 214.13 221.09 74.54 220.25 199.07 6.25%
EPS 15.35 21.27 11.49 -2.37 10.67 30.38 31.22 -12.45%
DPS 18.00 58.00 70.00 23.00 21.41 44.00 22.00 -3.69%
NAPS 9.886 9.7873 10.1957 10.1704 10.096 10.092 9.283 1.18%
Adjusted Per Share Value based on latest NOSH - 5,686,888
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/08/17 31/08/16 CAGR
RPS 271.44 178.10 210.06 216.44 72.80 215.01 193.84 6.51%
EPS 15.14 20.91 11.27 -2.32 10.42 29.66 30.40 -12.24%
DPS 17.75 57.00 68.67 22.52 20.91 42.95 21.42 -3.46%
NAPS 9.7506 9.6187 10.0022 9.9565 9.8596 9.8519 9.0388 1.43%
Price Multiplier on Financial Quarter End Date
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/08/17 31/08/16 CAGR
Date 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/08/17 30/08/16 -
Price 9.34 10.42 13.26 13.60 15.26 14.28 14.74 -
P/RPS 3.39 5.75 6.19 6.15 20.47 6.48 7.40 -13.60%
P/EPS 60.84 48.98 115.43 -574.68 143.05 47.00 47.21 4.86%
EY 1.64 2.04 0.87 -0.17 0.70 2.13 2.12 -4.69%
DY 1.93 5.57 5.28 1.69 1.40 3.08 1.49 4.96%
P/NAPS 0.94 1.06 1.30 1.34 1.51 1.41 1.59 -9.37%
Price Multiplier on Announcement Date
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/08/17 31/08/16 CAGR
Date 24/02/22 26/02/21 28/02/20 28/02/19 28/02/18 26/10/17 27/10/16 -
Price 9.00 10.10 12.10 13.42 15.70 14.34 14.32 -
P/RPS 3.27 5.57 5.65 6.07 21.06 6.51 7.19 -13.72%
P/EPS 58.62 47.48 105.33 -567.08 147.18 47.20 45.87 4.70%
EY 1.71 2.11 0.95 -0.18 0.68 2.12 2.18 -4.44%
DY 2.00 5.74 5.79 1.71 1.36 3.07 1.54 5.01%
P/NAPS 0.91 1.03 1.19 1.32 1.56 1.42 1.54 -9.38%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment